Treatment of Multiple Sclerosis With Intravenous Immunoglobulins-Reply

In reply  The article by Schuller and Govaerts,¹ has major differences compared with our study² regarding the patients treated, mode of treatment, dosage of drug used, and duration of treatment.Schuller and Govaerts¹ have treated patients with chronic progressive multiple sclerosis (MS), and their main results are related to the disability of the patients. We have treated pa